185 related articles for article (PubMed ID: 35544472)
1. Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population.
Adnan Y; Ali SMA; Awan MS; Idress R; Awan MO; Farooqui HA; Kayani HA
PLoS One; 2022; 17(5):e0267300. PubMed ID: 35544472
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Her-2 protein in histologically tumor-free margins of oral squamous cell carcinoma: An immunohistochemical study.
Kamat M; Puranik RS; Rai BD; Patil BR; Varsha VK; Kamat S
J Cancer Res Ther; 2023 Apr; 19(Supplement):S417-S421. PubMed ID: 37148009
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target.
Krishna A; Singh V; Singh N; Singh S; Mohanty SK; Singh R; Kumar V; Singh US; Singh RK
Clin Transl Oncol; 2022 Nov; 24(11):2191-2199. PubMed ID: 35918593
[TBL] [Abstract][Full Text] [Related]
4. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
5. Ki-67, CD105, and α-smooth muscle actin expression in oral squamous cell carcinoma corresponds with different forms of tobacco consumption habits.
Gadbail AR; Sarode SC; Chaudhary MS; Gondivkar SM; Tekade SA; Yuwanati M; Sarode GS; Hande A; Patil S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S197-S204. PubMed ID: 36510964
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of RKIP, TGM2, and CMTM4 expression in oral squamous cell carcinoma.
Luo T; Xu T; Ou Y; Ci H; Sun J
Medicine (Baltimore); 2024 Feb; 103(7):e37278. PubMed ID: 38363884
[TBL] [Abstract][Full Text] [Related]
7. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis.
Mirhashemi M; Sadeghi M; Ghazi N; Saghravanian N; Dehghani M; Aminian A
Ann Diagn Pathol; 2023 Dec; 67():152213. PubMed ID: 37856951
[TBL] [Abstract][Full Text] [Related]
9. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
11. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
[TBL] [Abstract][Full Text] [Related]
12. High Expression of Tomm34 and Its Correlations With Clinicopathology in Oral Squamous Cell Carcinoma.
Cai M; Tan R; Huang Y; Chen X; Kong Q; Guo K; Xu M
Pathol Oncol Res; 2021; 27():641042. PubMed ID: 34257607
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma.
Shimomura H; Sasahira T; Nakashima C; Shimomura-Kurihara M; Kirita T
Pathology; 2018 Oct; 50(6):642-647. PubMed ID: 30149992
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
16. ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas.
Ho CM; Hu FW; Lee SS; Shieh TM; Yu CH; Lin SS; Yu CC
J Oral Pathol Med; 2015 Oct; 44(9):693-8. PubMed ID: 25367287
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CD168 is related to poor prognosis in oral squamous cell carcinoma.
Zhu SW; Wang S; Wu ZZ; Yang QC; Chen DR; Wan SC; Sun ZJ
Oral Dis; 2022 Mar; 28(2):364-372. PubMed ID: 33386685
[TBL] [Abstract][Full Text] [Related]
18. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
[TBL] [Abstract][Full Text] [Related]
19. Corneodesmosin as a potential target of oral squamous cell carcinoma.
Di YB; Bao Y; Guo J; Liu W; Zhang SX; Zhang GH; Li TK
Medicine (Baltimore); 2022 Sep; 101(39):e28397. PubMed ID: 36181011
[TBL] [Abstract][Full Text] [Related]
20. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
